APLN and neoplasm: A recent publication found that Apelin depletion presents a double‐edged sword in glioblastoma, since it enhanced tumor cell invasion, while at the same time reducing vascular density, without accompanied changes in immune cell infiltration (Mastrella et al, 2019).